Skip to content

Bio-Techne

US · TECH #1365 by market cap Listed 1970
72.67 -0.03 -0.04%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 3 in the most recent period (2026/Q3).
  • Total institutional ownership fell 5.6 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
108.46% -5.65pp
Institutions
697 +3
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund77.16%
Hedge Fund16.05%
Public Company10.34%
Private Company1.71%
Government Pension Fund1.47%
Sovereign Wealth Fund0.90%
Family Office/Trust0.46%
Individual/Insider0.36%
Insurance Company0.16%

Top holders as of 2026-09-30

BlackRock 9.07% · 14.25M sh
FMR 8.14% · 12.76M sh
Vanguard Capital Management, LLC 6.53% · 10.25M sh
HBK Investments L.P. 4.34% · 6.83M sh
Vanguard Portfolio Management, LLC 4.04% · 6.35M sh
The Goldman Sachs Group, Inc. 3.99% · 6.27M sh
Fidelity International Ltd 3.99% · 6.27M sh
State Street Global Advisors 3.85% · 6.05M sh
Geode Capital Management, LLC 3.46% · 5.43M sh
Eaton Vance Management 3.04% · 4.78M sh
Invesco Capital Management LLC 2.89% · 4.54M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 27 buys · 23 sells

NameRoleStake
James Hippel Chief Financial Officer 0.11%
Kim Kelderman Chief Executive Officer 0.05%
John Higgins Independent Director 0.05%
Robert Baumgartner Independent Chairperson 0.04%
Roeland Nusse Former Independent Director 0.03%
William Geist President of Protein Sciences Segment 0.02%
Joseph Keegan Independent Director 0.01%
Alpna Seth Independent Director 0.01%
S.J. Vessey Independent Director 0.01%
Shane Bohnen Senior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer 0.01%
Julie Bushman Independent Director 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-31 Kim Kelderman Chief Executive Officer Sale to Issuer -2,385 $72.66
2026-10-31 James Hippel Chief Financial Officer Derivative Exercise and Sale -5,096 $72.66
2026-10-31 James Hippel Chief Financial Officer Derivative Exercise and Retained +6,449 --
2026-10-28 Robert Baumgartner Independent Chairperson Other Acquisition +2,750 --
2026-10-28 John Higgins Independent Director Other Acquisition +2,750 --
2026-10-28 Joseph Keegan Independent Director Other Acquisition +2,750 --
2026-10-28 Julie Bushman Independent Director Other Acquisition +2,750 --
2026-10-28 Alpna Seth Independent Director Other Acquisition +2,750 --
2026-10-28 Amy Herr Independent Director Other Acquisition +2,750 --
2026-10-28 Judith Klimovsky Independent Director Other Acquisition +2,750 --
2026-10-28 S.J. Vessey Independent Director Other Acquisition +2,750 --
2026-09-27 John Higgins Independent Director Derivative Exercise and Sale -5,562 $72.51
2026-09-27 John Higgins Independent Director Derivative Exercise and Retained +10,378 --
2026-09-21 Robert Baumgartner Independent Chairperson Derivative Exercise and Sale -5,559 $72.55
2026-09-21 Robert Baumgartner Independent Chairperson Derivative Exercise and Retained +10,381 --
2026-08-16 Kim Kelderman Chief Executive Officer Other Derivative Acquisition +151,172 --
2026-08-16 Steven Crouse President of Diagnostics & Spatial Biology Segment Other Derivative Acquisition +22,842 --
2026-08-16 James Hippel Chief Financial Officer Other Derivative Acquisition +58,897 --
2026-08-16 Amy Herr Independent Director Other Derivative Acquisition +1,381 --
2026-08-16 William Geist President of Protein Sciences Segment Other Derivative Acquisition +38,747 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:01:25 · For reference only, not investment advice and not tailored to your situation.

Bio-Techne discussion 0 comments

Add a comment